Stockscreener 앱 받기
83.89
4.86%
-4.145
Guardant Health Inc 주식(GH)의 최신 뉴스
Quest Diagnostics Expands Preventive Reach With Shield Colorectal Blood Test - simplywall.st
Capital International Investors Sells 287,217 Shares of Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Guardant Health at Leerink Global Healthcare: Strategic Growth and Partnerships - Investing.com Canada
Guardant Health's Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics - National Today
Guardant Health’s Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics - Yahoo Finance
Hidalgo Medina sells Guardant Health (GH) shares for $118,996 By Investing.com - Investing.com India
Hidalgo Medina sells Guardant Health (GH) shares for $118,996 - Investing.com
Guardant Health (NASDAQ:GH) Director Medina Manuel Hidalgo Sells 1,300 Shares - MarketBeat
Victory Capital Management Inc. Cuts Stake in Guardant Health, Inc. $GH - MarketBeat
Rhenman & Partners Asset Management AB Makes New Investment in Guardant Health, Inc. $GH - MarketBeat
How geopolitical risks impact Guardant Health Inc. (5GH) stockWeekly Trade Recap & Fast Exit/Entry Strategy Plans - Naître et grandir
Guardant Health Tour Highlights Colorectal Test Uptake And Valuation Gap - Yahoo Finance
BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now? - Finviz
TEM's Diagnostics Arm Expanding Rapidly: What's Driving the Growth? - Yahoo Finance
Legato Capital Management LLC Has $677,000 Position in Guardant Health, Inc. $GH - MarketBeat
Amova Asset Management Americas Inc. Has $47.12 Million Position in Guardant Health, Inc. $GH - MarketBeat
ARK Investment Management LLC Sells 2,028,263 Shares of Guardant Health, Inc. $GH - MarketBeat
Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and 908 Devices (MASS) - The Globe and Mail
Guardant Health Targets Early Detection Growth With New Partner And Acquisition - simplywall.st
Shield mobile tour brings FDA-approved screening to 100 communities, Guardant Health announces - Traders Union
Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America - Guardant Health
Segall Bryant & Hamill LLC Increases Stock Position in Guardant Health, Inc. $GH - MarketBeat
Guardant Health Launches Coast-to-Coast Screening Tour, Bringing - GuruFocus
Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened - Guardant Health
GH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Intech Investment Management LLC Has $3.19 Million Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
TD Asset Management Boosts Guardant Health Holdings - National Today
Guardant Health (GH) director acquires 154 shares via RSU vesting - Stock Titan
Guardant Health, Inc. (GH) Stock Analysis: A 41% Upside Potential With Strong Buy Ratings - DirectorsTalk Interviews
Does Guardant’s 2026 Outlook And Shelf Filing Reshape The Bull Case For Guardant Health (GH)? - simplywall.st
TD Asset Management Inc Boosts Holdings in Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. (GH) Strengthens Health Technology Portfolio with MetaSight Diagnostics Acquisition - Bitget
TD Cowen Health Care Conference - marketscreener.com
Guardant Health (GH) Is Down 8.9% After Issuing 2026 Guidance And New Equity Shelf Registration – Has The Bull Case Changed? - Yahoo Finance
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know - The Globe and Mail
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - ChartMill
Erste Asset Management GmbH Buys 66,617 Shares of Guardant Health, Inc. $GH - MarketBeat
Colon cancer screening expands with simple blood test as cases rise among under-50s - WLUK
Guardant Health (GH) Gained from Better-Than-Expected Results - Insider Monkey
Guardant Health Stock Hits Day Low at $94.62 Amid Price Pressure - Markets Mojo
Guardant Health, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:GH) 2026-02-25 - Seeking Alpha
Guardant Health Stock Hits Day Low of $93.79 Amid Price Pressure - Markets Mojo
Single‑Reference Disclosures and the Motivation‑to‑Combine Requirement - The National Law Review
Liquidity Mapping Around (GH) Price Events - Stock Traders Daily
Piper Sandler Raises Guardant Health (GH) Price Target to $130 | - GuruFocus
Vanguard Group Inc. Reduces Position in Guardant Health, Inc. $GH - MarketBeat
Guardant Health acquires Israeli healthtech MetaSight for up to $150M - MSN
Guardant Health pushes for AI-driven oncology breakthroughs at Cancer 2035 - Traders Union
Guardant Health slides as investors digest Q4 results and a risk-off tape - Quiver Quantitative
Guardant Health, Inc. (GH) Stock Analysis: A 26.53% Upside Potential in the Precision Oncology Market - DirectorsTalk Interviews
Guardant Health acquires MetaSight amid positive 2026 financial outlook - Yahoo Finance
0.42%
0.51%
자본화:
|
볼륨(24시간):